Verona Pharma (VRNA) SEC Filings & 10K Form

$15.23
-0.01 (-0.07%)
(As of 02:32 PM ET)

Recent Verona Pharma SEC Filings

DateFilerForm TypeView
04/02/2024
3:15 PM
Fisher Andrew (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:47 AM
Verona Pharma (Filer)
Form ARS
03/20/2024
7:46 AM
Verona Pharma (Filer)
Form DEF 14A
03/12/2024
6:45 PM
Gupta Rishi (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
3:18 PM
Verona Pharma (Filer)
Form PRE 14A
03/07/2024
8:40 PM
Fisher Andrew (Reporting)
Verona Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2024
7:15 PM
ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
8:00 AM
Verona Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
5:08 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
5:09 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:10 PM
Poll Claire (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:11 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:11 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
5:02 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
5:05 AM
Austwick Michael (Reporting)
Verona Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/02/2024
5:07 AM
Austwick Michael (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
5:02 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
3:15 PM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
4:09 PM
Edwards Martin (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
3:15 PM
EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
7:08 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
7:09 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
7:09 PM
Poll Claire (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
7:11 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:25 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
3:16 PM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
5:24 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
3:06 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
3:06 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
5:02 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:05 PM
ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2023
3:05 PM
ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
8:15 PM
Poll Claire (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
8:17 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
8:17 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
8:19 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:31 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:27 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:29 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
7:30 PM
Poll Claire (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:12 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide
08/03/2023
7:34 AM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
5:11 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
5:06 PM
Gupta Rishi (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
5:07 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
5:18 PM
ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2023
7:47 AM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2023
5:13 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:46 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
6:48 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
6:49 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
6:49 PM
Poll Claire (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
3:38 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2023
4:21 PM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:24 PM
Deschamps Lisa (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2023
3:16 PM
Verona Pharma (Subject)
Form SC 13G/A
04/25/2023
3:16 PM
Access Industries Holdings LLC (Filed by)
Access Industries Holdings LLC (Filed by)
Verona Pharma (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VRNA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners